Problems with anti-clotting drug.
D001709:Biotechnology; D004345:Drug Industry / Q000191:economics; D007603:Jurisprudence; D013300:Streptokinase / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D013300:Streptokinase; D010959:Tissue Plasminogen Activator